Longer reproductive window could up risk for Alzheimer’s disease
Jul 12, 2021
The authors suggest that longer exposure to endogenous estrogen may be associated with increased levels of Alzheimer’s disease biomarkers.
AAN issues review of evidence for aducanumab in Alzheimer’s disease
Mar 03, 2022
A class I study shows that single doses of aducanumab are safe and well-tolerated; class II studies show reduced amyloid deposition on brain PET at one year.
Exercise plus cognitive training may aid seniors with mild cognitive impairment
Jul 26, 2023
Vitamin D supplementation was not an aid alone or in combination.
Loss of smell, taste less likely with newer COVID-19 variants
May 18, 2022
A lower risk for developing chemosensory loss was observed with the alpha, delta and omicron variants.
ASA: Myocardial infarction may hasten cognitive decline in adults
Feb 03, 2022
Participants with incident MI had significantly faster declines in global cognition, memory and executive function than those without MI
MIND diet plus caloric restriction no better for cognition
Jul 19, 2023
A small improvement seen in global cognition scores, but it was no different from those following control diet with mild caloric restriction.
New Rx instructions tighten use of controversial Alzheimer’s disease drug
Jul 08, 2021
Major changes to prescribing instructions are rare, especially so soon after approval; it change could curb the drug’s use.
More older adults need help at home following hospitalization
Dec 08, 2021
Just under half of older adults report receiving help at home within three months of discharge.
Pricey Alzheimer drug drives spike in Medicare B premium: Officials
Nov 15, 2021
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
Smartphone-based measures can help ID frontotemporal lobar degeneration
Apr 01, 2024
Individuals with frontotemporal lobar degeneration were accurately differentiated from controls with smartphone tests.